Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions

Annette McWilliams, Calum MacAulay, Adi F. Gazdar, Stephen Lam

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Current approaches for the therapy of lung cancer, the majority of which being advanced cancers, have failed to impact on long term survival. The key to improvement lies in the combination of early diagnosis and the introduction of novel targeted therapies. In this article we review some of the innovative approaches, both imaging and molecular, that are currently under investigation for early detection. Because lung cancers may arise in the central or peripheral compartments of the lung, newer approaches must target tumours arising in both of these compartments. Specimens available for analysis include sputa and blood. Detection of genetic changes in peripheral blood is a promising avenue being explored by several groups. Molecular techniques discussed include gene mutations, detection of nuclear riboprotein, methylation related silencing of genes and malignancy associated changes. Newer imaging technologies include autofluorescence bronchoscopy, virtual bronchoscopy, optical coherent tomography and confocal microscopy. Although the impact of these new technologies on survival has not been determined, they offer a wide range of exciting new approaches. In time they may completely revamp the present highly conservative and unsuccessful approaches to early diagnosis.

Original languageEnglish (US)
Pages (from-to)6949-6959
Number of pages11
JournalOncogene
Volume21
Issue number45 REV. ISS. 5
DOIs
StatePublished - Oct 7 2002

Fingerprint

Molecular Imaging
Lung Neoplasms
Bronchoscopy
Early Diagnosis
Optical Tomography
Technology
Neoplasms
Gene Silencing
Sputum
Confocal Microscopy
Methylation
Lung
Mutation
Therapeutics
Genes

Keywords

  • Bronchoscopy
  • Diagnostic imaging
  • Lung neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions. / McWilliams, Annette; MacAulay, Calum; Gazdar, Adi F.; Lam, Stephen.

In: Oncogene, Vol. 21, No. 45 REV. ISS. 5, 07.10.2002, p. 6949-6959.

Research output: Contribution to journalArticle

McWilliams, A, MacAulay, C, Gazdar, AF & Lam, S 2002, 'Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions', Oncogene, vol. 21, no. 45 REV. ISS. 5, pp. 6949-6959. https://doi.org/10.1038/sj.onc.1205831
McWilliams, Annette ; MacAulay, Calum ; Gazdar, Adi F. ; Lam, Stephen. / Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions. In: Oncogene. 2002 ; Vol. 21, No. 45 REV. ISS. 5. pp. 6949-6959.
@article{156ab80163584a489b7c9b39834613d3,
title = "Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions",
abstract = "Current approaches for the therapy of lung cancer, the majority of which being advanced cancers, have failed to impact on long term survival. The key to improvement lies in the combination of early diagnosis and the introduction of novel targeted therapies. In this article we review some of the innovative approaches, both imaging and molecular, that are currently under investigation for early detection. Because lung cancers may arise in the central or peripheral compartments of the lung, newer approaches must target tumours arising in both of these compartments. Specimens available for analysis include sputa and blood. Detection of genetic changes in peripheral blood is a promising avenue being explored by several groups. Molecular techniques discussed include gene mutations, detection of nuclear riboprotein, methylation related silencing of genes and malignancy associated changes. Newer imaging technologies include autofluorescence bronchoscopy, virtual bronchoscopy, optical coherent tomography and confocal microscopy. Although the impact of these new technologies on survival has not been determined, they offer a wide range of exciting new approaches. In time they may completely revamp the present highly conservative and unsuccessful approaches to early diagnosis.",
keywords = "Bronchoscopy, Diagnostic imaging, Lung neoplasms",
author = "Annette McWilliams and Calum MacAulay and Gazdar, {Adi F.} and Stephen Lam",
year = "2002",
month = "10",
day = "7",
doi = "10.1038/sj.onc.1205831",
language = "English (US)",
volume = "21",
pages = "6949--6959",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "45 REV. ISS. 5",

}

TY - JOUR

T1 - Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions

AU - McWilliams, Annette

AU - MacAulay, Calum

AU - Gazdar, Adi F.

AU - Lam, Stephen

PY - 2002/10/7

Y1 - 2002/10/7

N2 - Current approaches for the therapy of lung cancer, the majority of which being advanced cancers, have failed to impact on long term survival. The key to improvement lies in the combination of early diagnosis and the introduction of novel targeted therapies. In this article we review some of the innovative approaches, both imaging and molecular, that are currently under investigation for early detection. Because lung cancers may arise in the central or peripheral compartments of the lung, newer approaches must target tumours arising in both of these compartments. Specimens available for analysis include sputa and blood. Detection of genetic changes in peripheral blood is a promising avenue being explored by several groups. Molecular techniques discussed include gene mutations, detection of nuclear riboprotein, methylation related silencing of genes and malignancy associated changes. Newer imaging technologies include autofluorescence bronchoscopy, virtual bronchoscopy, optical coherent tomography and confocal microscopy. Although the impact of these new technologies on survival has not been determined, they offer a wide range of exciting new approaches. In time they may completely revamp the present highly conservative and unsuccessful approaches to early diagnosis.

AB - Current approaches for the therapy of lung cancer, the majority of which being advanced cancers, have failed to impact on long term survival. The key to improvement lies in the combination of early diagnosis and the introduction of novel targeted therapies. In this article we review some of the innovative approaches, both imaging and molecular, that are currently under investigation for early detection. Because lung cancers may arise in the central or peripheral compartments of the lung, newer approaches must target tumours arising in both of these compartments. Specimens available for analysis include sputa and blood. Detection of genetic changes in peripheral blood is a promising avenue being explored by several groups. Molecular techniques discussed include gene mutations, detection of nuclear riboprotein, methylation related silencing of genes and malignancy associated changes. Newer imaging technologies include autofluorescence bronchoscopy, virtual bronchoscopy, optical coherent tomography and confocal microscopy. Although the impact of these new technologies on survival has not been determined, they offer a wide range of exciting new approaches. In time they may completely revamp the present highly conservative and unsuccessful approaches to early diagnosis.

KW - Bronchoscopy

KW - Diagnostic imaging

KW - Lung neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0037037788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037037788&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1205831

DO - 10.1038/sj.onc.1205831

M3 - Article

C2 - 12362276

AN - SCOPUS:0037037788

VL - 21

SP - 6949

EP - 6959

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 45 REV. ISS. 5

ER -